Stay updated with breaking news from Revascularization Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Penumbra (NYSE:PEN – Free Report) had its target price lifted by Royal Bank of Canada from $303.00 to $349.00 in a research report report published on Wednesday morning, FlyOnTheWall reports. Several other research analysts also recently commented on the stock. 58.com reissued a maintains rating on shares of Penumbra in a report on Wednesday, May […]
Penumbra, Inc. (NYSE:PEN – Get Free Report) CEO Adam Elsesser sold 9,666 shares of the stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $322.98, for a total value of $3,121,924.68. The transaction was disclosed in a filing with the SEC, which is available through the SEC […]
Penumbra (NYSE:PEN – Free Report) had its price target hoisted by Citigroup from $325.00 to $390.00 in a research report report published on Monday morning, FlyOnTheWall reports. A number of other research analysts also recently commented on PEN. Royal Bank of Canada boosted their price target on Penumbra from $289.00 to $303.00 in a research […]
Penumbra (NYSE:PEN – Free Report) had its target price increased by Royal Bank of Canada from $303.00 to $349.00 in a research note published on Wednesday, FlyOnTheWall reports. A number of other analysts have also issued reports on PEN. Wells Fargo & Company raised their price target on Penumbra from $291.00 to $320.00 in a […]
Penumbra, Inc. (NYSE:PEN – Free Report) EVP Johanna Roberts sold 900 shares of Penumbra stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $340.18, for a total transaction of $306,162.00. Following the completion of the sale, the executive vice president now owns 65,437 shares of the company’s […]